These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 23318460)

  • 21. Expression of co-stimulatory molecule B7-H4 in patients suffering from rheumatoid arthritis.
    Chen L; Lu Y; Wang F; Zhou M; Chu Y; Ding W; Liu C; Xie J; Wu C; Jiang J
    Immunol Lett; 2013; 154(1-2):25-30. PubMed ID: 23973734
    [TBL] [Abstract][Full Text] [Related]  

  • 22. MicroRNA-125b-5p modulates the inflammatory state of macrophages via targeting B7-H4.
    Diao W; Lu L; Li S; Chen J; Zen K; Li L
    Biochem Biophys Res Commun; 2017 Sep; 491(4):912-918. PubMed ID: 28754594
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [B7-H4-mediated immunoresistance is supressed by PI3K/Akt/mTOR pathway inhibitors].
    Zeng S; Song H; Chen Y; Xie W; Zhang L
    Mol Biol (Mosk); 2016; 50(6):1007-1013. PubMed ID: 28064317
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Development of a novel anti-B7-H4 antibody enhances anti-tumor immune response of human T cells.
    Miao G; Sun X
    Biomed Pharmacother; 2021 Sep; 141():111913. PubMed ID: 34328096
    [TBL] [Abstract][Full Text] [Related]  

  • 25. B7-H4 promotes tumor growth and metastatic progression in lung cancer by impacting cell proliferation and survival.
    Zhang X; Cai L; Zhang G; Shen Y; Huang J
    Oncotarget; 2017 Mar; 8(12):18861-18871. PubMed ID: 28061481
    [TBL] [Abstract][Full Text] [Related]  

  • 26. The deubiquitinase USP2a promotes tumor immunosuppression by stabilizing immune checkpoint B7-H4 in lung adenocarcinoma harboring EGFR-activating mutants.
    Lu Y; Sun Y; Zhang J; Kong M; Zhao Z; Sun B; Wang Y; Jiang Y; Chen S; Wang C; Tong Y; Wen L; Huang M; Wu F; Zhang L
    Cancer Lett; 2024 Aug; 596():217020. PubMed ID: 38849009
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant expression of B7-H4 correlates with poor prognosis and suppresses tumor-infiltration of CD8+ T lymphocytes in human cholangiocarcinoma.
    Zhao X; Guo F; Li Z; Jiang P; Deng X; Tian F; Li X; Wang S
    Oncol Rep; 2016 Jul; 36(1):419-27. PubMed ID: 27177355
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Silencing of B7-H4 suppresses the tumorigenicity of the MGC-803 human gastric cancer cell line and promotes cell apoptosis via the mitochondrial signaling pathway.
    Zhou D; Zhou Y; Li C; Yang L
    Int J Oncol; 2018 Apr; 52(4):1267-1276. PubMed ID: 29436630
    [TBL] [Abstract][Full Text] [Related]  

  • 29. The B7-H4 gene induces immune escape partly via upregulating the PD-1/Stat3 pathway in non-small cell lung cancer.
    Yuan L; Ye J; Fan D
    Hum Immunol; 2020 May; 81(5):254-261. PubMed ID: 32113654
    [TBL] [Abstract][Full Text] [Related]  

  • 30. B7-H4, a molecule of the B7 family, negatively regulates T cell immunity.
    Sica GL; Choi IH; Zhu G; Tamada K; Wang SD; Tamura H; Chapoval AI; Flies DB; Bajorath J; Chen L
    Immunity; 2003 Jun; 18(6):849-61. PubMed ID: 12818165
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The negative co-signaling molecule b7-h4 is expressed by human bone marrow-derived mesenchymal stem cells and mediates its T-cell modulatory activity.
    Xue Q; Luan XY; Gu YZ; Wu HY; Zhang GB; Yu GH; Zhu HT; Wang M; Dong W; Geng YJ; Zhang XG
    Stem Cells Dev; 2010 Jan; 19(1):27-38. PubMed ID: 19788399
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Granulocyte-Macrophage Colony-Stimulating Factor-Activated Neutrophils Express B7-H4 That Correlates with Gastric Cancer Progression and Poor Patient Survival.
    Shan ZG; Yan ZB; Peng LS; Cheng P; Teng YS; Mao FY; Fan K; Zhuang Y; Zhao YL
    J Immunol Res; 2021; 2021():6613247. PubMed ID: 33763491
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Novel recombinant human b7-h4 antibodies overcome tumoral immune escape to potentiate T-cell antitumor responses.
    Dangaj D; Lanitis E; Zhao A; Joshi S; Cheng Y; Sandaltzopoulos R; Ra HJ; Danet-Desnoyers G; Powell DJ; Scholler N
    Cancer Res; 2013 Aug; 73(15):4820-9. PubMed ID: 23722540
    [TBL] [Abstract][Full Text] [Related]  

  • 34. A T-cell-engaging B7-H4/CD3-bispecific Fab-scFv Antibody Targets Human Breast Cancer.
    Iizuka A; Nonomura C; Ashizawa T; Kondou R; Ohshima K; Sugino T; Mitsuya K; Hayashi N; Nakasu Y; Maruyama K; Yamaguchi K; Akiyama Y
    Clin Cancer Res; 2019 May; 25(9):2925-2934. PubMed ID: 30737243
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Roles of immune inhibitory molecule B7-H4 in cervical cancer.
    Han S; Li Y; Zhang J; Liu L; Chen Q; Qian Q; Li S; Zhang Y
    Oncol Rep; 2017 Apr; 37(4):2308-2316. PubMed ID: 28260085
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Donor and host B7-H4 expression negatively regulates acute graft-versus-host disease lethality.
    Saha A; Taylor PA; Lees CJ; Panoskaltsis-Mortari A; Osborn MJ; Feser CJ; Thangavelu G; Melchinger W; Refaeli Y; Hill GR; Munn DH; Murphy WJ; Serody JS; Maillard I; Kreymborg K; van den Brink M; Dong C; Huang S; Zang X; Allison JP; Zeiser R; Blazar BR
    JCI Insight; 2019 Oct; 4(19):. PubMed ID: 31578305
    [TBL] [Abstract][Full Text] [Related]  

  • 37. The inhibitory role of b7-h4 in antitumor immunity: association with cancer progression and survival.
    He C; Qiao H; Jiang H; Sun X
    Clin Dev Immunol; 2011; 2011():695834. PubMed ID: 22013483
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Expression of costimulatory molecule B7-H4 in human malignant tumors.
    Zheng X; Li XD; Wu CP; Lu BF; Jiang JT
    Onkologie; 2012; 35(11):700-5. PubMed ID: 23147549
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Molecular Pathways: Evaluating the Potential for B7-H4 as an Immunoregulatory Target.
    MacGregor HL; Ohashi PS
    Clin Cancer Res; 2017 Jun; 23(12):2934-2941. PubMed ID: 28325750
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Aberrant expression of B7-H4 and B7-H5 contributes to the development of cutaneous squamous cell carcinoma.
    Chen L; Zhou B; Tang M; Yao Y; Zhao Y; Hu Y; Lin Y; Ji J; Jiao Q
    Arch Dermatol Res; 2024 Jun; 316(7):382. PubMed ID: 38850312
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.